Brent Colson

Brent Colson is an accomplished Territory Business Manager with extensive experience in the pharmaceutical industry. Currently at Alkermes since November 2022, Brent has previously held similar roles at Intercept Pharmaceuticals, focusing on Rare/Orphan Disease, and at Takeda, with a strong emphasis on Neuroscience, managing relationships with healthcare professionals and key opinion leaders. Additional experience includes positions at Shire, where Brent promoted treatments for ADHD, and at The Janssen Pharmaceutical Companies, achieving significant market share growth. Brent’s career started at Schering-Plough Pharmaceuticals and includes a Bachelor of Science in Management from the Georgia Institute of Technology.